Abstract: Stromal cell-derived factor-1 is a dominant chemokine in bone marrow that is known to be involved in infl ammatory diseases, including rheumatoid arthritis. Its role in bone repair has recently been demonstrated. The purpose of this study was to investigate the role of extraneous stromal cell-derived factor-1 in fracture healing.
M
illions of people fully recover from fractures annually, but 5% to 10% go on to develop a delayed union or nonunion. 1 Impaired fracture healing can result in functional disability; therefore, there is an urgent need for a bioactive agent to stimulate bone formation during the treatment of fracture healing.
Stromal derived factor-1 belongs to the chemokine family, was originally isolated from bone marrow stromal cells, 2 and is known to be constitutively produced by fi broblasts and marrow endothelial cells. 3 It has been shown previously that stromal cell-derived factor-1 and its receptor CXCR4 play an important role in cell migration and embryonic development. 4 Stromal cell-derived factor-1 is also a powerful chemoattractant for the localization of CXCR4 positive bone marrow stromal stem cells into bone marrow. 3, 5 Recently, stromal cell-derived factor-1 has been proven to be induced in the periosteum of injured bone and to promote endochondral bone repair by recruiting mesenchymal stem cells to the site of injury. 6 Thus, stromal cell-derived factor-1 has been recognized as a critical regulator of bone cell function. Additionally, the local delivery of stromal cell-derived factor-1 into injured tissue promotes the recruitment of circulating mesenchymal stromal and progenitor cells to lesions in the heart. 7, 8 However, the involvement of the exogenous stromal cell-derived factor-1 in bone repair has not been elucidated.
In this study, we hypothesized that exogenous stromal cell-derived factor-1 plays an important role in enchondral bone formation during fracture healing. Using a mouse tibia closed fracture model, and analysis methods such as radiography, histological evaluation, and real-time PCR (the target genes information are shown in Table 1 ), we demonstrated that exogenous stromal cell-derived factor-1 enhanced bone repair. Our results suggest new strategies for the therapeutic use of exogenous stromal cell-derived factor-1 to promote successful bone healing.
MATERIALS AND METHODS

Experimental Animals
Forty 8-week-old male mice (C57BL/6N) were used in the experiments. The mice were used to create fracture models as previously described. 9 Briefl y, animals were anesthetized by intraperitoneal injection of a Ketamine-Medetomidine cocktail (75ϩ1 mg/kg). The animals were prepared for surgery by shaving and scrubbing of right hind limbs.
A longitudinal short incision was made at the knee, and a 0.5-mm hole was drilled above the tibial tuberosity. A 30G stainless-steel needle (Hengyuan, Shenzhen, China) was introduced into the intramedullary canal of the tibia. A closed transverse middiaphyseal tibia fracture was created by 3-point bending in the right tibia. Immediately after fracture, a carrier (200 l of fi brin gel) containing 100 g of stromal cell-derived factor-1␣ or carrier alone was applied to the 
Radiology Evaluation
With radiographs, a nonuniformly composed material can be viewed. By using the physical properties of the radiograph, an image can display clear areas of different density and composition. A heterogeneous beam radiograph can be produced by a radiograph generator and is projected toward the target object. According to the density and composition of the different areas of the object, a proportion of radiographs are absorbed by the object. The radiographs that pass through are then captured behind the object by a detector (fi lm sensitive to radiographs or a digital detector) that gives a 2-dimensional photograph of all the structures superimposed on each other. The fracture healing progress is followed by the use of radiology.
Histological Evaluation
After the mice were sacrifi ced, samples of the fractured tibias were removed, fi xed in 4% formalin, decalcifi ed, dehydrated, embedded in paraffi n, cut into 4-m-thick sections, and stained using Safranin-O/Fast Green. The samples were then evaluated by light microscopy (Eclipse 55i, Nikon Shanghai, China).
RNA Extraction
The RNeasy Fibrous Tissue Mini kit (Qiagen, Shanghai, China) was used to extract RNA from the fracture calluses with 1 modifi cation. After sacrifi cing the mice, fracture calluses were saved in RNAlater (Qiagen), and stored at Ϫ80°C until RNA extraction. The calluses were ground into a fi ne powder using a mortar and pestle with liquid nitrogen, and extracted according to the instructions provided with the kit.
Real-Time PCR Analysis
Primers were designed using Primer Premier 5.0 software (Premier Biosoft International, Palo Alto, California) as shown in Table 2 . To quantify the target genes, mRNA was performed by real-time quantitative reverse transcriptase PCR. One g total RNA was transcribed into cDNA using iScrip (Bio-Rad, Shanghai, China). Forty ng/l of the resulting cDNA was used as the template to quantify the relative content of mRNA by RT-PCR using Sso Fast EvaGreen Supermix (Bio-Rad) with the CFX 96 Real Time PCR system (Bio-Rad). To normalize the data, mRNA expression of a housekeeping gene, 18S, was also determined. The cycle threshold values for 18S RNA and that of samples were measured and calculated by Excel (Offi ce 2007, Microsoft, Redmond, Washington). Relative transcript levels were calculated as xϭ2
Ϫ△△Ct , in which △△Ct = △EϪ△C, and △EϭCt-exp ϪCt 18s ; △CϭCt ctl ϪCt 18s .
Statistical Analysis
Data were analyzed by the 2-tailed Student t tests in Excel (Offi ce 2007). Signifi cance was defi ned at the PϽ.05 level. All means are expressed as ϮSEM.
RESULTS
Radiology Image Analysis
In both groups, periosteal callus formation became visible by day 9 after fracture induction ( Figure 1) . A larger radiolucent area was seen in the periosteal calluses in the nonstromal cell-derived factor-1 injected group relative to the stromal cell-derived factor-1-injected group (Figure 1, arrows) , suggesting that exogenous stromal cell-derived factor-1 enhanced bone formation. Formation of osseous bridging over the fracture site was completed by day 21 in both groups, and the size of the bony calluses in each group were almost equivalent ( Figure 1 ). In contrast, the stromal cell-derived factor-1 treated group showed more nonradiopacity.
mRNA Expressions in Soft Callus
To investigate the mechanism of increased bone formation in the stromal cell-derived factor-1-treated tibia fracture mice, 3 animals from each group were sacrifi ced on Day 9 postfracture and total RNA was isolated from the soft callus for RT-PCR analysis. The mRNA expression of collagen type II, vascular endothe- Table 1 Brief Instructions About the Target Genes Analyzed by RT-PCR ■ the cutting edge lial growth factor, fi broblast growth factor-1, and runt-related transcription factor 2 were examined by RT-PCR analyses ( Figure 2 ). We found that on day 9, after fracture, the stromal cell-derived factor-1 treated mouse had signifi cantly higher collagen type II mRNA levels (2.1-fold increase) (Figure 2A) , vascular endothelial growth factor mRNA levels (3.2-fold increase) ( Figure  2B ), fi broblast growth factor mRNA levels (4.0-fold increase) ( Figure 2C ), and runtrelated transcription factor 2 mRNA levels (2.1-fold increase) ( Figure 2D ) compared with untreated mice.
Histology Analysis
Histological staining of cartilage with Safranin-O/Fastgreen at 14 days postfracture showed that minimal cartilage remained in the stromal cell-derived factor-1 treated specimens (2 of 6) ( Figure 3A) . However, cartilage remnants were present in many of the nonstromal cell-derived factor-1 treated specimens at this time point (5 of 6) ( Figure 3B) . Analysis of the fracture callus demonstrated a signifi cantly reduced number of hypertrophic cartilage cells (3.1 fold) in stromal cell-derived factor-1-treated mice compared with the nontreated group ( Figure 3C ).
mRNA Expressions in Hard Callus
In the late stage of fracture healing, we investigated osteogenic gene expression levels. 3 Animals from each group were sacrifi ced on Day 21 postfracture and total RNA was isolated from the hard callus for RT-PCR analysis. The mRNA expression of bone sialoprotein, bone morphogenetic protein, alkaline phosphatase, and collagen type X, were examined by RT-PCR analysis (Figure 4) . We found that, 21 days after fracture, the stromal ■ the cutting edge cell-derived factor-1-treated mouse had signifi cantly higher bone sialoprotein mRNA levels (4.3 fold increase) ( Figure  4A ), bone morphogenetic protein mRNA levels (3.2 fold increase) ( Figure 4B ), alkaline phosphatase mRNA levels (4.4 fold increase) ( Figure 4C ), and collagen type X mRNA levels (1.8 fold increase) ( Figure 4D ) compared with the untreated mice. These data suggest that stromal cell-derived factor-1 has the potential to induce mineralization and osteogenesis in the hard callus during fracture healing, and confi rmed the fi nding in the radiographic imaging study, which showed more bone formation in the stromal cell-derived factor-1 treated group.
DISCUSSION
In this study, we demonstrated that a single injection of exogenous stromal cellderived factor-1 during endochondral bone repair can induce more rapid fracture healing. Fracture healing can occur through 2 distinct processes. If bone segments are stabilized, mesenchymal precursor cells differentiate directly into bone-forming osteoblasts in a process called intramembranous ossifi cation. Alternatively, most fractures possess some level of mechanical instability and heal by the process of endochondral ossifi cation. Bony callus formation is preceded by a cartilaginous template. 10 In this study, we used the intramedullary pin, an unstable fi xation, to fi x the tibia fracture, and because of this, endochondral ossifi cation occurred in the model. Stromal cell-derived factor-1 has previously been shown to be an important factor in bone marrow stromal stem cell function and bone repair.
2,7-9 Thus, we hypothesized that exogenous stromal cell-derived factor-1 could have the ability to induce fracture healing.
We used an exogenous stromal cell-derived factor-1-treated mouse tibia fracture model to verify this hypothesis. We compared radiographs during the fracture-healing process and observed enhanced healing progress in the stromal cell-derived factor-1-treated group with more callus formation in the early stage of bone repair, whereas gaps were still detected in the untreated group. This differential increase in callus formation suggests that a single injection of exogenous stromal cell-derived factor-1 may accelerate bone repair.
To determine the reason why there would be more new bone formation in the stromal cell-derived factor-1-treated mice, we next investigated the relative gene expression levels in soft calluses. Collagen type II is known as a matrix component and is secreted by chondrocytes in the early stages of endochondral ossifi cation.
11
Figure 2:
There was a signifi cantly higher mRNA expression of angiogenesis promoting genes in the fracture soft callus of stromal cell-derived factor-1 treated mice compared to untreated mice on Day 9 determined by real-time polymerase chain reaction analysis. Data are shown as mean ϮSEM of triplicate wells, and representative data of independent experiments are shown. Stromal cell-derived factor-1-treated mice had signifi cantly more collagen type 2 mRNA levels (2.1 fold, Pϭ.014) (A), vascular endothelial growth factor mRNA levels (3.2 fold, Pϭ.016) (B), fi broblast growth factor mRNA levels (4.0 fold, Pϭ.0003) (C), and runt-related transcription factor 2 mRNA levels (2.1 fold, Pϭ.012) (D), compared to untreated mice. *PϽ.05, **PϽ.001, nϭ6. 
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ORTHO0611Li Fibroblast growth factor-1 is involved in angiogenesis and has the capacity to induce the process of healing. Vascular endothelial growth factor, one of the proangiogenic factors, is essential for callus formation and mineralization in response to bone injury. 10, [14] [15] [16] Our results show that stromal cell-derived factor-1-treated mice had signifi cantly more angiogenesis, osteoblast, and chondrogenic gene expression. We also verifi ed that the stromal cell-derived factor-1 treated mice healed faster than untreated mice in the midstage of fracture healing by the histologic fi ndings.
In the late stage of fracture healing, we studied the relative gene expression levels in hard calluses. Alkaline phosphatase and bone sialoprotein are involved in tissue mineralization. Bone morphogenetic protein-7 has been demonstrated to have the ability to induce all of the genetic markers of osteoblast differentiation in many cell types. 17 The expression of collagen type X, a marker for hypertrophic chondrocytes during endochondral ossifi cation, occurs later than that of other cartilage specifi c genes and may play a role in the mineralization of cartilage. 18 We observed that stromal cellderived factor-1-treated mice had more mineralization and osteogenic gene expression compared with nonstromal cell-derived factor-1-treated mice.
These results favor the notion that exogenous stromal cell-derived factor-1 contributes to increased fracture healing. It has been demonstrated that stromal cell-derived factor-1 is an essential molecule for the migration of mesenchymal stem cells to sites of bone repair in vivo. 6 Mesenchymal stem cells can differentiate into multiple cell lineages and promote structural and functional repairs in many organs including bones, making mesenchymal stem cells an interesting candidate for cell-based bone regeneration. 19 From the results of the present study, it appears that exogenous stromal cell-derived factor-1 has the potential to recruit mesenchymal stem cells to the injury site and promote endochondral bone repair in the same manner as endogenous stromal cell-derived factor-1. More work needs to be done to elucidate the mechanism of cell migration caused by exogenous stromal cell-derived factor-1. The performance of mechanical testing and bone mineral density tests to confi rm whether exogenous stromal cell-derived factor-1 can increase callus mechanical strength should be performed in future studies.
This study demonstrates, for the fi rst time, that exogenous stromal cell-derived factor-1 contributes to endochondral bone repair. More investigation needs to be undertaken to reveal the function of exogenous stromal cell-derived factor-1 in endochondral fracture healing, which is likely to open a new era including a minimally-invasive strategy for the clinical therapeutic use of stromal cellderived factor-1 to achieve faster bone repair. 
